MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...

Adults with neuropathic pain use cannabis products more frequently than those without neuropathic pain. | Cannabis Sciences ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

SciatiSoothe is a natural nerve health support supplement made with plant herbs and natural minerals. The formula is ...

For executives of Lexicon Pharmaceuticals Inc., the missed primary endpoint in the phase IIb Progress study testing pilavapadin, its non-opioid candidate, in adults with moderate to severe diabetic ...

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader inquiring about a solution for snoring.

A 45-year-old man diagnosed with trigeminal neuralgia, a condition causing severe facial nerve pain, received successful treatment at a Del.

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

The company has chosen to move ahead to Phase III trials with its 10mg dose after it saw a 1.74-point reduction in pain score ...

Reinard gave birth to her daughter, Laena Roan, on Jan. 25, 2025, about nine weeks after her spine surgery. As her surgical scar still heals, Reinard said she hopes to show it to her daughter someday ...